BIOCRYST PHARMACEUTICALS, INC. (BCRX) Net margin 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) net profit margin by fiscal year — reported net income divided by reported revenue.
30.2%FY2025 · since FY2016: -209.3% → 30.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 30.2% | +49.9 pp |
| FY2024 | -19.7% | +48.6 pp |
| FY2023 | -68.4% | +22.9 pp |
| FY2022 | -91.2% | +25.9 pp |
| FY2021 | -117.1% | +909.2 pp |
| FY2020 | -1026.4% | -803.4 pp |
| FY2019 | -223.0% | +267.3 pp |
| FY2018 | -490.3% | -229.1 pp |
| FY2017 | -261.2% | -51.9 pp |
| FY2016 | -209.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice